Sanofi
Latest statistics and disclosures from Sanofi's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MGTX, INBX, NVAX, ANAB, AgomAb Therapeutics NV, and represent 89.02% of Sanofi's stock portfolio.
- Added to shares of these 1 stock: AgomAb Therapeutics NV (+$29M).
- Started 1 new stock position in AgomAb Therapeutics NV.
- Sanofi was a net buyer of stock by $29M.
- Sanofi has $336M in assets under management (AUM), dropping by 8.23%.
- Central Index Key (CIK): 0001121404
Tip: Access up to 7 years of quarterly data
Positions held by Sanofi consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sanofi
Sanofi holds 9 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Meiragtx Holdings (MGTX) | 31.4 | $106M | 12M | 8.66 |
|
|
| Inhibrx Biosciences (INBX) | 23.2 | $78M | 1.2M | 67.23 |
|
|
| Novavax Com New (NVAX) | 16.7 | $56M | 6.9M | 8.14 |
|
|
| Anaptysbio Inc Common (ANAB) | 9.0 | $30M | 822k | 36.97 |
|
|
| Agomab Therapeutics NV Sponsored Ads | 8.7 | $29M | NEW | 2.8M | 10.49 |
|
| Maplight Therapeutics (MPLT) | 5.5 | $19M | 912k | 20.33 |
|
|
| Immuneering Corp Class A Com (IMRX) | 4.2 | $14M | 2.7M | 5.27 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.7 | $2.5M | 815k | 3.08 |
|
|
| Q32 Bio (QTTB) | 0.5 | $1.6M | 244k | 6.42 |
|
Past Filings by Sanofi
SEC 13F filings are viewable for Sanofi going back to 2025
- Sanofi 2026 Q1 filed May 7, 2026
- Sanofi 2025 Q4 filed Feb. 11, 2026
- Sanofi 2025 Q3 filed Nov. 4, 2025
- Sanofi 2025 Q2 filed July 29, 2025